MARX Biotech Co., Ltd. (TPEX:7731)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
4.220
-0.040 (-0.94%)
Sep 9, 2026, 1:43 PM CST

MARX Biotech Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
73.3132.7774.67152.8327.730.18
Short-Term Investments
-23.5---
Cash & Short-Term Investments
73.3134.7778.17152.8327.730.18
Cash Growth
167.02%-55.52%-48.85%451.08%15479.78%-
Accounts Receivable
82.967.24120.0298.4254.95-
Other Receivables
109.94309.2410.714.62--
Receivables
192.83376.48130.73103.0454.95-
Inventory
95.55115.53169.887012-
Prepaid Expenses
19.1512.2723.5713.980.83-
Other Current Assets
10.669.224.953.190.56-
Total Current Assets
391.49548.27407.3343.0496.070.18
Property, Plant & Equipment
209.53209.16217.194.264.73-
Long-Term Investments
-----13.5
Goodwill
20.8820.8826.255.37--
Other Intangible Assets
45.0847.3265.3630.1--
Long-Term Deferred Tax Assets
--6.564.921.940.09
Other Long-Term Assets
7.397.098.547.150.450.03
Total Assets
674.36832.72731.2394.85103.1913.8

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
58.8751.7788.8823.725.26-
Accrued Expenses
34.1356.3662.7639.7712.980.5
Short-Term Debt
70126.2298-10-
Current Portion of Long-Term Debt
-16.25.27---
Current Portion of Leases
0.590.13.91.262.97-
Current Income Taxes Payable
-8.94--3.41-
Current Unearned Revenue
34.0537.3940.2625.082.28-
Other Current Liabilities
37.510.99.3511.24.60.16
Total Current Liabilities
235.13307.88308.43101.0441.50.66
Long-Term Debt
149164.17165.04---
Long-Term Leases
0.4-5.110.620.87-
Long-Term Deferred Tax Liabilities
1.241.291.380.20.08-
Total Liabilities
385.76473.34479.95101.8642.450.66

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
130.5130.5126.5124.5140.88.05
Additional Paid-In Capital
192.32184.86220.48186.0317.983.21
Retained Earnings
-34.9144.02-95.73-17.551.951.89
Shareholders' Equity
288.6359.38251.25292.9960.7313.14
Total Liabilities & Equity
674.36832.72731.2394.85103.1913.8

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
219.99306.69277.321.8813.84-
Net Cash (Debt)
-146.68-271.92-199.15150.9413.890.18
Net Cash Growth
---986.39%7705.62%-
Net Cash Per Share
-0.28-0.52-0.400.470.040.01
Filing Date Shares Outstanding
521.98521.98505.98498.06163.2132.18
Total Common Shares Outstanding
521.98521.98505.98498.06163.2132.18
Working Capital
156.36240.3998.87242.0154.57-0.48
Book Value Per Share
0.550.690.500.590.370.41
Tangible Book Value
222.64291.18159.64257.5260.7313.14
Tangible Book Value Per Share
0.430.560.320.520.370.41
Land
129.46129.46129.46---
Buildings
69.1369.139.13---
Machinery
11.6310.4869.132.71.03-
Construction In Progress
---00.02-
Leasehold Improvements
6.175.973.751.10.44-